Cooper Companies | COO - Interest Expense On Debt


Cooper Companies reported $20.9M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Abbott USD 299M 231M Jun/2026
Align Technology USD 6.93M 9.11M Mar/2026
AtriCure USD 1.21M 159K Mar/2026
Bausch Health Companies USD 402M 5M Mar/2026
Baxter International USD 78M 20M Mar/2026
Bayer EUR 675M 87M Dec/2025
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Boston Scientific USD 96M 6M Jun/2026
Cooper Companies USD 20.9M 1.5M Mar/2026
Dentsply International USD 24M 2M Mar/2026
Dexcom USD 3.1M 1.1M Mar/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Globus Medical USD 5.44B 5.44B Mar/2026
Haemonetics USD 7.4M 190K Dec/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 14.7M 5.5M Mar/2026
Integra LifeSciences USD 22.99M 529K Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 176M 5M Mar/2026
Merit Medical Systems USD 12.12M 5.59M Jun/2026
Novartis USD 281M 8M Sep/2025
ResMed USD 8.79M 14.55M Sep/2025
STAAR Surgical USD 800K 799K Sep/2025
Steris USD 14.9M 0 Dec/2025
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 1.15B Mar/2026
Teleflex USD 25.72M 2.43M Mar/2026
Zimmer Biomet Holdings USD 68.8M 3.1M Mar/2026